Cargando…

Comparison of SARC-F Score among Gastrointestinal Diseases

SARC-F is a screening tool for sarcopenia. We sought to compare the SARC-F scores of patients with different gastrointestinal diseases (n = 1282 (762 males): upper gastrointestinal disease (UGD, n = 326), lower gastrointestinal disease (LGD, n = 357), biliary and pancreatic disease (BPD, n = 416), a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ushiro, Kosuke, Nishikawa, Hiroki, Matsui, Masahiro, Ogura, Takeshi, Takeuchi, Toshihisa, Goto, Masahiro, Nakamura, Shiro, Kakimoto, Kazuki, Miyazaki, Takako, Fukunishi, Shinya, Asai, Akira, Ohama, Hideko, Yokohama, Keisuke, Yasuoka, Hidetaka, Higuchi, Kazuhide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469770/ https://www.ncbi.nlm.nih.gov/pubmed/34575208 http://dx.doi.org/10.3390/jcm10184099

Ejemplares similares

Prognostic Impact of the SARC-F Score in Gastrointestinal Advanced Cancers
por: Matsui, Masahiro, et al.
Publicado: (2021)

The Relationship between the SARC-F Score and the Controlling Nutritional Status Score in Gastrointestinal Diseases
por: Ikegami, Takako, et al.
Publicado: (2022)

The Relevance in the Neutrophil to Lymphocyte Ratio and the SARC-F Score in Gastrointestinal Diseases
por: Yamasaki, Eiki, et al.
Publicado: (2022)

Grip Strength in Patients with Gastrointestinal Diseases
por: Asaishi, Ken, et al.
Publicado: (2022)

Accurate SARC-F Score in Patients with Liver Disease
por: Matsui, Masahiro, et al.
Publicado: (2023)

Liver dysfunction is associated with poor prognosis in patients after immune checkpoint inhibitor therapy
por: Yokohama, Keisuke, et al.
Publicado: (2020)

Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
por: Yasuoka, Hidetaka, et al.
Publicado: (2020)

The preventive effect of the impaired liver function for antiemetic therapy against chemotherapy-induced nausea and vomiting in hepatocellular carcinoma patients
por: Nishikawa, Tomohiro, et al.
Publicado: (2017)

Association between Administration of Antithrombotics and Intraperitoneal Hemorrhage in Patients Undergoing Percutaneous Interventions for Liver Diseases
por: Asai, Akira, et al.
Publicado: (2021)

Inflammatory Bowel Disease and Sarcopenia: Its Mechanism and Clinical Importance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression
por: Asai, Akira, et al.
Publicado: (2020)

Exacerbation of liver dysfunction in non-alcoholic steatohepatitis patients during the coronavirus disease 2019 (COVID-19) pandemic
por: Asai, Akira, et al.
Publicado: (2021)

Sitagliptin can inhibit the development of hepatic steatosis in high-fructose diet-fed ob/ob mice
por: Sujishi, Tetsuya, et al.
Publicado: (2015)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Hepatectomy and liver regeneration in the results of treatment of colorectal liver metastasis
por: Inoue, Yoshihiro, et al.
Publicado: (2020)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Inoue, Yoshihiro, et al.
Publicado: (2021)

Cancer Cachexia: Its Mechanism and Clinical Significance
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Endoscopic Ultrasound-Guided Pancreatic Transmural Stenting and Transmural Intervention
por: Ogura, Takeshi, et al.
Publicado: (2020)

RETRACTED ARTICLE: Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer
por: Aoki, Masahiko, et al.
Publicado: (2019)

Retraction Note: Novel Therapeutic Approach Using Drug-loaded Adipose-derived Stem Cells for Pancreatic Cancer
por: Aoki, Masahiko, et al.
Publicado: (2021)

CD34(+)CD10(+)CD19(−) Cells in Patients with Unhealthy Alcohol Use Stimulate the M2b Monocyte Polarization
por: Asai, Akira, et al.
Publicado: (2022)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Fr581 EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
por: Hirata, Yuki, et al.
Publicado: (2021)

Risk Factors for Nephrotoxicity due to Tacrolimus Therapy for Ulcerative Colitis
por: Nakata, Satoshi, et al.
Publicado: (2022)

Endoscopic ultrasound-guided choledochoduodenostomy for obstructive jaundice with venous collaterals around the bile duct wall (with video)
por: Ogura, Takeshi, et al.
Publicado: (2017)

Therapeutic Drug Monitoring of Golimumab for the Prediction of Long-Term Clinical Remission in Patients with Ulcerative Colitis
por: Tawa, Hideki, et al.
Publicado: (2022)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Effects of Oral L-Carnitine on Liver Functions after Transarterial Chemoembolization in Intermediate-Stage HCC Patients
por: Hassan, Abeer, et al.
Publicado: (2015)

Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis
por: Kinoshita, Naohiko, et al.
Publicado: (2022)

Body Composition Analysis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Onishi, Saori, et al.
Publicado: (2023)

Insulin Resistance: A Marker for Fat-to-Lean Body Composition in Japanese Adults
por: Matsui, Masahiro, et al.
Publicado: (2023)

Association between the Suita Score and Body Composition in Japanese Adults: A Large Cross-Sectional Study
por: Onishi, Saori, et al.
Publicado: (2023)

Effect of an Electronic Alert System on Hepatitis B Virus Reactivation in Patients Receiving Immunosuppressive Drug Therapy
por: Asai, Akira, et al.
Publicado: (2022)

Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition
por: Kawasaki, Yuka, et al.
Publicado: (2023)

Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
por: Numa, Keijiro, et al.
Publicado: (2023)

Metabolic Syndrome and Sarcopenia
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Sarcopenia and Frailty in Liver Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2021)

Dual antiplatelet therapy does not affect the incidence of low-dose aspirin-induced small intestinal mucosal injury in patients after percutaneous coronary intervention for coronary stenosis: a multicenter cross-sectional study
por: Hara, Azusa, et al.
Publicado: (2018)

Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation
por: Kubota, Minori, et al.
Publicado: (2019)

Prognostic Impact of Ectopic Fat Deposition within Psoas Muscle in Stage IV Gastric Cancer Patients Undergoing Systemic Chemotherapy
por: Ikegami, Takako, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_leo98ep1f2hn10rpkjo9888bsv